FundingMachine
Menu

Funding Atlas programme

CRI Impact Grant

Cancer Research Institute

JurisdictionUnited StatesFunding typeGrant

Documented facts

Key facts

Funder
Cancer Research Institute
Jurisdiction
United States
Record type
Opportunity
Funding type
Grant
Amount
300,000
Next deadline
1 December 2026

Published rule provenance

Eligibility information

Country / jurisdiction

Rule not encoded

Organisation type

Rule not encoded

Company size

Rule not encoded

Stage

Rule not encoded

Therapeutic area

Rule not encoded

Amount sought

Rule not encoded

Further quoted conditions

Eligibility rule, quoted from the funder: area

In partnership with the Chordoma Foundation (CF), CRI invites LOIs focused on accelerating the development of effective immunotherapies for chordoma, a rare type of cancer that occurs in the bones of the skull base and spine.
Quoted source

Site note: This record is not advice or a funder decision.